JP2016501865A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501865A5 JP2016501865A5 JP2015544133A JP2015544133A JP2016501865A5 JP 2016501865 A5 JP2016501865 A5 JP 2016501865A5 JP 2015544133 A JP2015544133 A JP 2015544133A JP 2015544133 A JP2015544133 A JP 2015544133A JP 2016501865 A5 JP2016501865 A5 JP 2016501865A5
- Authority
- JP
- Japan
- Prior art keywords
- therapy
- composition
- tlves
- tms
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002560 therapeutic procedure Methods 0.000 claims 24
- 239000000203 mixture Substances 0.000 claims 23
- 238000011491 transcranial magnetic stimulation Methods 0.000 claims 15
- 239000005557 antagonist Substances 0.000 claims 9
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical group C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 claims 5
- 229960003299 ketamine Drugs 0.000 claims 5
- 230000037452 priming Effects 0.000 claims 3
- 230000033764 rhythmic process Effects 0.000 claims 3
- 210000003625 skull Anatomy 0.000 claims 3
- 230000000638 stimulation Effects 0.000 claims 3
- 208000024891 symptom Diseases 0.000 claims 3
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000003444 anaesthetic effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000003461 thalamocortical effect Effects 0.000 claims 2
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 claims 1
- 208000013586 Complex regional pain syndrome type 1 Diseases 0.000 claims 1
- 206010013654 Drug abuse Diseases 0.000 claims 1
- 102000018899 Glutamate Receptors Human genes 0.000 claims 1
- 108010027915 Glutamate Receptors Proteins 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 claims 1
- 201000001947 Reflex Sympathetic Dystrophy Diseases 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 230000005856 abnormality Effects 0.000 claims 1
- 208000028683 bipolar I disease Diseases 0.000 claims 1
- 208000025307 bipolar depression Diseases 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000003928 nasal cavity Anatomy 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 208000011117 substance-related disease Diseases 0.000 claims 1
- 230000000542 thalamic effect Effects 0.000 claims 1
- 231100000886 tinnitus Toxicity 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261729625P | 2012-11-25 | 2012-11-25 | |
| US61/729,625 | 2012-11-25 | ||
| US13/826,250 US8974365B2 (en) | 2012-11-25 | 2013-03-14 | Treatment of thalamocortical dysrhythmia |
| US13/826,250 | 2013-03-14 | ||
| PCT/US2013/071275 WO2014081948A1 (en) | 2012-11-25 | 2013-11-21 | Treatment of thalamocortical dysrhythmia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229815A Division JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501865A JP2016501865A (ja) | 2016-01-21 |
| JP2016501865A5 true JP2016501865A5 (enExample) | 2017-01-12 |
Family
ID=50773848
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015544133A Pending JP2016501865A (ja) | 2012-11-25 | 2013-11-21 | 視床皮質律動異常の処置 |
| JP2018229815A Pending JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
| JP2020117607A Pending JP2020180141A (ja) | 2012-11-25 | 2020-07-08 | 視床皮質律動異常の処置 |
| JP2022161851A Pending JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
| JP2024208873A Pending JP2025029043A (ja) | 2012-11-25 | 2024-11-29 | 視床皮質律動異常の処置 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018229815A Pending JP2019065021A (ja) | 2012-11-25 | 2018-12-07 | 視床皮質律動異常の処置 |
| JP2020117607A Pending JP2020180141A (ja) | 2012-11-25 | 2020-07-08 | 視床皮質律動異常の処置 |
| JP2022161851A Pending JP2022188221A (ja) | 2012-11-25 | 2022-10-06 | 視床皮質律動異常の処置 |
| JP2024208873A Pending JP2025029043A (ja) | 2012-11-25 | 2024-11-29 | 視床皮質律動異常の処置 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US8974365B2 (enExample) |
| EP (2) | EP3915551A1 (enExample) |
| JP (5) | JP2016501865A (enExample) |
| KR (5) | KR20220132667A (enExample) |
| CN (1) | CN104981265A (enExample) |
| CA (1) | CA2896568C (enExample) |
| ES (1) | ES2882619T3 (enExample) |
| IL (2) | IL273912B2 (enExample) |
| MX (1) | MX2015006444A (enExample) |
| WO (1) | WO2014081948A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10155114B2 (en) * | 2014-06-03 | 2018-12-18 | Dirk De Ridder | Systems and methods of treating a neurological disorder in a patient |
| US10118038B2 (en) * | 2015-03-24 | 2018-11-06 | Dirk De Ridder | Methods of neuromodulation |
| US10201708B2 (en) | 2014-10-29 | 2019-02-12 | Dirk De Ridder | Method of treating a neurological disorder using network stimulation |
| IL296167A (en) * | 2016-02-21 | 2022-11-01 | Tech Innosphere Eng Ltd | Noninvasive electric brain stimulation system |
| US10596378B2 (en) * | 2016-10-18 | 2020-03-24 | Joseph Rustick | Method for treatment of depression using synaptic pathway training |
| US9950189B1 (en) * | 2016-10-20 | 2018-04-24 | Neuro-Laser Foundation Inc. | Treatment methodologies using light therapy |
| US10905897B2 (en) * | 2016-10-20 | 2021-02-02 | Neuro-Laser Foundation, Inc. | Synergistic treatment methodologies using light therapy |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| WO2019103597A1 (en) * | 2017-11-22 | 2019-05-31 | Excelsior Pharmatech Labs | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| KR102099200B1 (ko) * | 2017-12-18 | 2020-04-09 | 서울대학교산학협력단 | 뇌 자극 장치 |
| HUE058320T2 (hu) | 2017-12-29 | 2022-07-28 | Celon Pharma Sa | Száraz por alakú ketamin készítmény pulmonáris adagolásra kezelésnek ellenálló depresszió esetén |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| EP3849410A4 (en) | 2018-09-14 | 2022-11-02 | Neuroenhancement Lab, LLC | SYSTEM AND METHODS FOR ENHANCEMENT OF SLEEP |
| CN109481845B (zh) * | 2018-12-28 | 2022-04-01 | 深圳先进技术研究院 | 一种作用于不同脑区的经颅磁刺激的方法和相关装置 |
| CN110064117B (zh) * | 2019-03-27 | 2021-06-01 | 佛山职业技术学院 | 一种基于呐喊声音的心理宣泄交互方法及装置 |
| WO2020196888A1 (ja) | 2019-03-28 | 2020-10-01 | 住友建機株式会社 | ショベル及び施工システム |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| US12059565B1 (en) * | 2019-12-19 | 2024-08-13 | Washington University | Methods and systems for modulating unconsciousness or anesthesia in a subject |
| CN113041501A (zh) * | 2021-03-22 | 2021-06-29 | 东南大学 | 联合磁刺激系统靶向视觉皮层快速抗抑郁的方法 |
| WO2022235576A1 (en) * | 2021-05-03 | 2022-11-10 | Wang Michael Z | Methods and compositions for treating depression |
| ES2994763B2 (es) * | 2023-07-25 | 2025-11-03 | Nauta Technomedical Res S L | Sistema de neuroestimulacion magnetica hiperbarica con ajuste parametrico semi automatico personalizable |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5084007A (en) * | 1989-08-11 | 1992-01-28 | Malin David H | Method for chemical promotion of the effects of low current transcranial electrostimulation |
| US6132361A (en) * | 1994-11-28 | 2000-10-17 | Neotonus, Inc. | Transcranial brain stimulation |
| US5763393A (en) | 1996-05-17 | 1998-06-09 | Neurotherapeutics L.P. | Neuroactive peptides |
| US6176242B1 (en) * | 1999-04-30 | 2001-01-23 | Medtronic Inc | Method of treating manic depression by brain infusion |
| US6591138B1 (en) * | 2000-08-31 | 2003-07-08 | Neuropace, Inc. | Low frequency neurostimulator for the treatment of neurological disorders |
| US20110307029A1 (en) * | 2008-08-06 | 2011-12-15 | Cerephex Corporation | Brain stimulation methods for treating central sensitivity |
| US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
| US8052591B2 (en) * | 2006-05-05 | 2011-11-08 | The Board Of Trustees Of The Leland Stanford Junior University | Trajectory-based deep-brain stereotactic transcranial magnetic stimulation |
| JP2008514612A (ja) | 2004-09-23 | 2008-05-08 | ミシャロウ、アレクサンダー | 対抗適応を誘発することにより神経伝達物質系を調節する方法 |
| US7613520B2 (en) * | 2004-10-21 | 2009-11-03 | Advanced Neuromodulation Systems, Inc. | Spinal cord stimulation to treat auditory dysfunction |
| CN101686945A (zh) * | 2004-11-23 | 2010-03-31 | 埃德莫斯药品有限公司 | 包含持续释放的包衣或基质和nmda受体拮抗剂的组合物，以及向受治疗者施用该nmda受体拮抗剂的方法 |
| US7619007B2 (en) * | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| US8676330B2 (en) * | 2009-03-20 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache and comorbid disorders |
| CN101432011A (zh) * | 2006-02-27 | 2009-05-13 | 亚历山大·米哈洛 | 通过诱导逆适应调节神经递质系统的方法 |
| WO2007103475A2 (en) * | 2006-03-07 | 2007-09-13 | Beth Israel Deaconess Medical Center, Inc. | Transcranial magnetic stimulation (tms) methods and apparatus |
| AU2007229866A1 (en) * | 2006-03-22 | 2007-10-04 | Mount Sinai School Of Medicine | Intranasal administration of ketamine to treat depression |
| US7949403B2 (en) * | 2007-02-27 | 2011-05-24 | Accelerated Care Plus Corp. | Electrical stimulation device and method for the treatment of neurological disorders |
| JP2011520815A (ja) * | 2008-05-09 | 2011-07-21 | エモリー・ユニバーシテイ | 精神神経障害治療のためのｎｍｄａ受容体拮抗薬 |
| US8591419B2 (en) * | 2008-07-14 | 2013-11-26 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Methods and devices for modulating cellular activity using ultrasound |
| EP2321007B1 (en) * | 2008-08-04 | 2016-10-12 | The Trustees of Columbia University in the City of New York | Apparatus and systems for magnetic stimulation |
| US8674095B2 (en) | 2008-12-19 | 2014-03-18 | Afraxis Holdings, Inc. | Compounds for treating neuropsychiatric conditions |
| CN102413873B (zh) * | 2009-03-02 | 2014-07-16 | 耶德研究和发展有限公司 | 用于经颅磁刺激的磁结构和定时方案 |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| CA2776770A1 (en) * | 2009-10-09 | 2011-04-14 | Afraxis, Inc. | 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| CN102753019A (zh) | 2009-12-15 | 2012-10-24 | 纽罗普公司 | 用于治疗神经系统病症的化合物 |
| WO2011123548A2 (en) * | 2010-04-02 | 2011-10-06 | Neostim, Inc | Neuromodulation of deep-brain targets by transcranial magnetic stimulation enhanced by transcranial direct current stimulation |
| US20140058189A1 (en) * | 2012-02-20 | 2014-02-27 | William F. Stubbeman | Systems and methods using brain stimulation for treating disorders |
-
2013
- 2013-03-14 US US13/826,250 patent/US8974365B2/en active Active
- 2013-11-21 KR KR1020227032393A patent/KR20220132667A/ko not_active Ceased
- 2013-11-21 MX MX2015006444A patent/MX2015006444A/es unknown
- 2013-11-21 KR KR1020257009861A patent/KR20250046361A/ko active Pending
- 2013-11-21 KR KR1020237031477A patent/KR20230141875A/ko not_active Ceased
- 2013-11-21 KR KR1020207028289A patent/KR20200117062A/ko not_active Ceased
- 2013-11-21 EP EP21172714.4A patent/EP3915551A1/en active Pending
- 2013-11-21 ES ES13856126T patent/ES2882619T3/es active Active
- 2013-11-21 EP EP13856126.1A patent/EP2922591B1/en active Active
- 2013-11-21 KR KR1020157015152A patent/KR20150091323A/ko not_active Ceased
- 2013-11-21 CA CA2896568A patent/CA2896568C/en active Active
- 2013-11-21 WO PCT/US2013/071275 patent/WO2014081948A1/en not_active Ceased
- 2013-11-21 CN CN201380069664.7A patent/CN104981265A/zh active Pending
- 2013-11-21 IL IL273912A patent/IL273912B2/en unknown
- 2013-11-21 JP JP2015544133A patent/JP2016501865A/ja active Pending
-
2015
- 2015-02-27 US US14/634,305 patent/US9649501B2/en active Active
- 2015-05-21 IL IL238979A patent/IL238979B/en active IP Right Grant
-
2017
- 2017-04-19 US US15/491,612 patent/US10716950B2/en active Active
-
2018
- 2018-12-07 JP JP2018229815A patent/JP2019065021A/ja active Pending
-
2020
- 2020-07-08 JP JP2020117607A patent/JP2020180141A/ja active Pending
- 2020-07-20 US US16/933,397 patent/US20210101015A1/en not_active Abandoned
-
2022
- 2022-10-06 JP JP2022161851A patent/JP2022188221A/ja active Pending
-
2023
- 2023-09-05 US US18/461,499 patent/US20240207630A1/en active Pending
-
2024
- 2024-11-29 JP JP2024208873A patent/JP2025029043A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016501865A5 (enExample) | ||
| JP2020180141A5 (enExample) | ||
| IL273912B1 (en) | Treatment of thalamocortical dysrhythmia | |
| CA2923685C (en) | Application of r-ketamine and salt thereof as pharmaceuticals | |
| Kim et al. | Efficacy and safety of lidocaine infusion treatment for neuropathic pain: a randomized, double-blind, and placebo-controlled study | |
| Zhang et al. | Research advances in the clinical application of esketamine | |
| JP2016518387A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| JP2014528901A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| JP2011173928A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| CN106562952B (zh) | 氯胺酮在治疗重性抑郁障碍中的应用 | |
| JP2009529502A5 (enExample) | ||
| JP2015515985A5 (enExample) | ||
| JP2017510607A5 (enExample) | ||
| RU2012108656A (ru) | Применение 4-аминопиридина для улучшения состояния при нейрокогнитивном и/или нейропсихиатрическом нарушении у пациентов с демиелинизирующими и другими заболеваниями нервной системы | |
| JP2016510343A5 (enExample) | ||
| JP2015522015A5 (enExample) | ||
| JP2016507500A5 (enExample) | ||
| JP2015522077A5 (enExample) | ||
| JP2018529766A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2020500930A5 (enExample) | ||
| MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. |